Craig Collard - Sep 10, 2021 Form 4 Insider Report for OPIANT PHARMACEUTICALS, INC. (OPNT)

Role
Director
Signature
/s/ Craig Collard
Stock symbol
OPNT
Transactions as of
Sep 10, 2021
Transactions value $
$174,110
Form type
4
Date filed
9/13/2021, 04:08 PM
Previous filing
Jun 16, 2021
Next filing
Sep 15, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OPNT Common Stock Purchase $174K +9.58K +239.43% $18.18 13.6K Sep 10, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $18.06 to $18.20. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.